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We required a method to accurately quantify broad ranges of DNA, and tested both 
spectrophotometry and fluorometry. Both have known advantages and disadvantages: in 
particular, spectrophotometry is known to be inaccurate at low DNA concentrations, while 
fluorometry can produce biased plasmid DNA results due to conformational changes.
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Comparing spectrophotometry (Nanodrop 2000) to fluorometry (Qubit 2.0 dsDNA HS and BR 
Assay), we found that linear DNA and plasmid DNA were most accurate and precise on the 
Nanodrop when at concentrations above 30 ng/µL, incurring at most 5.17% error (Figure S1, 
Table S1). However, for linear DNA from 2-30 ng/µL both of the dsDNA HS and BR Assays 
had superior accuracy and precision, incurring at most 12.02% error. For plasmid DNA from 2-
30 ng/µL only the dsDNA BR Assay using a linear standard was accurate and precise, incurring 
5.07% error. Based on these results, for subsequent data we quantified all constructs above 30 
ng/µL on the Nanodrop, end-working concentration linear DNA from 2-30 ng/µL using the 
Qubit dsDNA HS Assay, and end-working concentration plasmid DNA from 2-30 ng/µL either 




DNA Quantification Materials and Methods 
A Nanodrop 2000 UV-Vis spectrophotometer (Thermo Fisher Scientific) and a Qubit 2.0 
fluorometer (Invitrogen) were used to measure dsDNA concentration. Per run, either 500 ng/µL 
of 1 kb DNA ladder (New England Biolabs) or 500 ng/µL of supercoiled DNA ladder (New 
England Biolabs) were diluted 1:2 down to 0.98 ng/µL in TE buffer and used as experimental 
samples. For the Nanodrop, 2 µL of sample was used to determine concentration. For the Qubit, 
2 µL of sample was combined with 198 µL of supplied reagent:buffer to determine 
concentration. Different standards were tested for the Qubit, depending on the assay (dsDNA BR 
or dsDNA HS) and the type of DNA quantified (linear or plasmid). Linear standards were 
supplied by the manufacturer; plasmid standards consisted of pUC19 vector at 1000 ng/µL (New 
England Biolabs) diluted 1:10 in TE for the dsDNA BR assay or 1:100 for the dsDNA HS assay. 
  
Supplemental S2.  
 
The following plasmids, relevant DNA pieces, and primers were used in the study, along with 







pBEST-p15A-Pl-tetO1-UTR1-lacI-T500 1 45784  
pBEST-p15A-Pl-tetO1-UTR1-deGFP-T500 
 
2 45392  
pBEST-p15A-Pl-lacO1-UTR1-TetR-T500 3  Derived from 2 with replacement of 
“deGFP” with “tetR” coding 
sequence 
pBEST_OR2-OR1-Pr_UTR1_deCFP_T500 18  Derived from 21 with replacement of  
“deGFP” with “deCFP” coding 
sequence 
pBEST_OR2-OR1-Pr_UTR1_deGFP-T500 21 40019  
pBADmod1-linker2-gamS 22 45833  
pBEST_OR2-OR1-Pr-UTR1_ClpX-T500 48  Derived from 21 with “ClpX” coding 
sequence from Genbank U00096.3 
substituted for “deGFP” – used as 
T500 template for 134-137. 
pBEST-colE1-Pl-tetO1-UTR1-deGFP-T500 58  Derived from 21 with replacement of 




Derived from gltB and lhr genes 
from Genbank U00096.3 cloned into 
21 - directly after T500 from 
<3354960 (AAAACTA…):3356959 
(…GTGCTTC)> and directly before 
OR2-OR1-Pr from 
<1731632(ACGGTGG…):1733631(
…GGTCCGG). G->A silent 




105  Derived from 21 with silent 
mutations to make BsaI, BbsI 
compatible 
pBEST-Pl-tetO1-tetR-linker-deGFP-T500 109  Post cloned 4-piece from 
Isothermal/Golden Gate assembly 
(GGA), using sequences from 2 (Pl-
tetO1-UTR1), 3 (tetR+linker from 
primer extension), 21 (linker from 




113  Derived from 1 with silent mutations 
to make BsaI, BbsI compatible 
pBEST-p15A-OR2-OR1-Pr-UTR1-deGFP-
T500 
121  Derived from 1 with promoter 
replacement 
pBEST-p15A-Pl-tetO1-deGFP-T500 122  “ 
pBEST-p15A-Pl-lacO1-deGFP-T500 123  “ 
pBEST-p15A-J23113-deGFP-T500 124  “ 
pBEST-p15A-J23114-deGFP-T500 125  “ 
pBEST-p15A-J23116-deGFP-T500 126  “ 
pBEST-p15A-J23150-deGFP-T500 127  “ 
pBEST-p15A-J23106-deGFP-T500 128  “ 
pBEST-p15A-J23151-deGFP-T500 129  “ 
pBEST-p15A-J23100-deGFP-T500 130  “ 
pBEST-p15A-J23101-deGFP-T500 131  “ 
pBEST-p15A-J23102-deGFP-T500 132  “ 
pBEST-p15A-pNull-deGFP-T500 133  “ 
P3U2C7T2-v1-1 (Pl-lacO1-deGFP) 134  Post cloned 5-piece GGA using 
sequences from 105 (backbone), 3 
(Pl-lacO1), 21 (UTR1), 21 (deGFP), 
and 48 (T500). 
P4U2C8T2-v1-1 (Pl-tetO1-deCFP) 135  Post cloned 5-piece GGA using 
sequences from 105 (backbone), 2 
(Pl-tetO1), 21 (UTR1), 18 (deCFP), 
and 48 (T500). 
P3U2C5T2-v1-2 (Pl-lacO1-tetR) 136  Post cloned 5-piece GGA using 
sequences from 105 (backbone), 3 
(Pl-lacO1), 21 (UTR1), 3 (tetR), and 
48 (T500). 
P4U2C6T2-v1-2 (Pl-tetO1-lacI) 137  Post cloned 5-piece GGA using 
sequences from 105 (backbone), 2 
(Pl-tetO1), 21 (UTR1), 113 (lacI), 
and 48 (T500). 
 


































































































Isothermal assembly piece 1 to make 
109, 2 w/ ZS30432f 
CHB TTTAAGAAGGAGATATACCACATGTCTAGA
TTAGATAAAAGTAAAGTGAT 
Isothermal assembly piece 2 to make 
109, 3 w/ CHB-R 
CHB-R ACCAGACTGGAAGTACAGGTTTTCACCAGA
CCCACTTTCACATTTAAGT 
Isothermal assembly piece 2 to make 
109, 3 w/ CHB 
CHC AACCTGTACTTCCAGTCTGGTGGTGCTATGG
AGCTTTTCACTGGC 
Isothermal assembly piece 3 to make 
109, 21 w/ CHC-R 
CHC-R CTTTGAGTGAGCTGATACCGCAGTCATAAG
TGCGGCGA 
Isothermal assembly piece 3 to make 
109, 21 w/ CHC 
CHD CGTCGCCGCACTTATGACTGCGGTATCAGCT
CACTCAAAG 
Isothermal assembly piece 4 to make 
109, 105 w/ ZS30432r 
ZS3033f TGAGCTAACACCGTGCGT 0 bp protection, 21 w/ ZS3033rb 
ZS3033rb ACAGAAAAGCCCGCCTTTCGGCGGGCTTTG
CTCGAGTTAGATC 
0 bp protection, 21 w/ ZS3033f 
ZS3034f CATGCTGAGCTAACACCG 5 bp protection, 21 w/ ZS3034ra 
ZS3034ra TCGACACAGAAAAGCCCG 5 bp protection, 21 w/ ZS3034f 
ZS3035f GTGTGTGCTGTTCCGCT 25 bp protection, 21 w/ ZS3035r 
ZS3035r AAGGCTCTCAAGGGCATC 25 bp protection, 21 w/ ZS3035f 
ZS3036f AAAACCGAATTTTGCTGG 100 bp protection, 21 w/ ZS3036r 
ZS3036r ATGATAAAGAAGACAGTCATAAGTGCG 100 bp protection, 21 w/ ZS3036f 
ZS3037f TGGCGAATCCTCTGACC 250 bp protection, 21 w/ ZS3037r or 
121-133 w/ ZS30610r or 58, 134-137 
w/ ZS3037r 
ZS3037r TCTTTCCTGCGTTATCCC 250 bp protection, 21 w/ ZS3037f or 
134-137 w/ ZS3037f 
ZS3038f AAAGGGAATAAGGGCGACA 500 bp protection, 21 w/ ZS3038r 
ZS3038r AGCGCCACGCTTCCC 500 bp protection, 21 w/ ZS3038f 
ZS30412f TCCGGTGAGCTAACACC 0 bp protection, 87 w/ ZS303412r 
ZS30412r GTTTTACAGAAAAGCCCGC 0 bp protection, 87 w/ ZS303412f 
ZS30413f AGAAGTGAATGATCTACCGGTC 5 bp protection, 87 w/ ZS303413r 
ZS30413r AAGAGCATCCCGACAGC 5 bp protection, 87 w/ ZS303413f 
ZS30414f ATTACTCGCCCCAGAGGTT 25 bp protection, 87 w/ ZS303414r 
ZS30414r GACAAGGTTTCGCGTTG 25 bp protection, 87 w/ ZS303414r 
ZS30415f GTGGGGAAATCTTCTGCC 100 bp protection, 87 w/ ZS303415r 
ZS30415r CGGCGGGCGATAAAC 100 bp protection, 87 w/ ZS303415f 
ZS30416f GCTACGGCATCATCAGTC 250 bp protection, 87 w/ ZS303416r 
ZS30416r GGTGATGGTGTTGATTTCAC 250 bp protection, 87 w/ ZS303416f 
ZS30417f ACGGTGGCGAAATTCA 500 bp protection, 87 w/ ZS303417r 
ZS30417r GAAGCACAGGCCCACTAC 500 bp protection, 87 w/ ZS303417f 
ZS30432f ATGACTATCGCACCATCAGCTAACGATATC
CGCCTGAT 
Isothermal assembly piece 1 to make 
109, 2 w/ CHA-R 
ZS30432r GCATCAGGCGGATATCGTTAGCTGATGGTG
CGATAGTCA 
Isothermal assembly piece 4 to make 
109, 21 w/ CHD 
ZS30433f 
ATCTAGGTCTCTAACGATATCCGCCTGAT 

























GGA “C7”, “C8”, 21 w/ ZS30523r or 
18 w/ ZS30523r 
ZS30513r GTCCGGGTCTCACGACTCTCAAGGGCATCG
GT 
GGA “T2”, 21 w/ ZS30524f 
ZS30514f GTCCTGGTCTCTATGCGTGGTTGTCTTCGTA
CGTCCGTCACGTTC 
GGA “v1-1”, 105 w/ ZS30514r 
ZS30514r ATATAGGTCTCTGTCGGGCATTGTCTTCGCT
CCTTCCGGTGG 
GGA “v1-1”, 105 w/ ZS30514f 
ZS30515f TAGCGGGTCTCTGTCGTGCCTTGTCTTCGTT
ACGTCCGTCACGTTC 
GGA “v1-2”, 105 w/ ZS30528r 
ZS30521r CGTAAGGTCTCAGCTTGCTGTGCTCAGTATC
TCT 
GGA “P4”, 2 w/ ZS3057f 
ZS30522f AGCCAGGTCTCAAAGCAATAATTTTGTTTA
ACTT 
GGA “U2”, 21 w/ ZS3059r 
ZS30523r 
TTAGTGGTCTCATTCATTAGATCCCGGCGGC 
GGA “C7”, “C8”, 21 w/ ZS30512f or 
18 w/ ZS30512f 
ZS30524f GGCTCGGTCTCATGAAGCATCTGGTGAATA
ACTCGAG 
GGA “T2”, 21 w/ ZS30513r 
ZS30528r AGGTGGGTCTCTATGCTATGTTGTCTTCGCT
CCTTCCGGTGG 
GGA “v1-2”, 105 w/ ZS30515f 
ZS30534r CGTAAGGTCTCAGCTTGCTGTGCTCAGTATC
TTGT 
GGA “P3”, 3 w/ ZS3057f 
ZS3057f 
AGAACGGTCTCAGCATTGCTGTTCCGCTGG 
GGA “P3”, “P4”, 3 w/ ZS30534r or 
2 w/ ZS30521r 
ZS3059r TCCCCGGTCTCACATGGTATATCTCCTTCTT
A 
GGA “U2”, 21 w/ ZS30522f 
ZS30610r 
GAAGATCATCTTATTAATCAGATAAAATAT 
250 bp protection, 121-133 w/ 
ZS3037f 
ZS30611f ACGAGGCCCTTTCGTCT 250 bp protection, 109 w/ ZS30611r 
ZS30611r ACGAGGCCCTTTCGTCT 250 bp protection, 109 w/ ZS30611f 
ZS3064f T*G*AGCTAACACCGTGCGT 0 bp protection, 2 TS, 21 w/ ZS3064r 
ZS3064r A*C*AGAAAAGCCCGCCTTTCGGCGGGCTTT
GCTCGAGTTAGATC 
0 bp protection, 2 TS, 21 w/ ZS3064f 
ZS3065f T*G*A*G*C*TAACACCGTGCGT 0 bp protection, 5 TS, 21 w/ ZS3065r 
ZS3065r A*C*A*G*A*AAAGCCCGCCTTTCGGCGGGC
TTTGCTCGAGTTAGATC 
0 bp protection, 5 TS, 21 w/ ZS3065f 
ZS3066f C*A*TGCTGAGCTAACACCG 5 bp protection, 2 TS, 21 w/ ZS3066r 
ZS3066r T*C*GACACAGAAAAGCCCGCCTTTCGGCGG
GCTTTGCTCG 
5 bp protection, 2 TS, 21 w/ ZS3066f 
ZS3067f C*A*T*G*C*TGAGCTAACACCG 5 bp protection, 5 TS, 21 w/ ZS3067r 
ZS3067r T*C*G*A*C*ACAGAAAAGCCCGCCTTTCGG
CGGGCTTTGCTCG 
5 bp protection, 5 TS, 21 w/ ZS3067f 
ZS3068f 
T*G*GCGAATCCTCTGACC 
























































Inducible promoters Pl-tetO1 and Pl-lacO1 in linear and plasmid DNA were fit to a standard Hill 
function to approximate Michaelis-Menten dynamics using Prism 6.0 software (GraphPad 








Table S1. Comparing absorbance and fluorometric quantifications of linear and plasmid 








(ng/µL) % Error 
Actual 
(ng/µL) % Error 
Actual 
(ng/µL) % Error 
500 490.8 +/ 4.2 1.84% 471.7 +/- 41.3 5.67% 
250 251.3 +/- 2.1 0.53% 229.7 +/- 2.5 8.13% 
125 126.7 +/- 3.6 1.36% 114.7 +/- 1.2 8.27% 55 56.00% 
62.5 63.80 +/- 3.10 2.08% 53.63 +/-2.24 10.99% 55.33 +/- 1.15 11.47% 
31.25 32.87 +/- 2.61 5.17% 27.73 +/- 2.00 11.25% 28.07 +/- 2.38 10.19% 
15.625 17.33 +/- 1.99 10.93% 13.97 +/- 1.40 10.61% 13.77 +/- 1.76 11.89% 
7.8125 9.60 +/- 1.84 22.88% 6.97 +/- 0.92 10.74% 7.02 +/- 1.09 10.14% 
3.90625 5.67 +/- 1.50 45.07% 3.51 +/- 0.82 10.06% 3.44 +/- 0.69 12.02% 
1.953125 3.70 +/- 0.82 89.44% 1.77 +/- 0.54 9.38% 1.78 +/- 0.32 8.86% 
0.976563 2.50 +/- 1.13 156.00% 1.17 +/- 0.05 19.30% 0.91 +/- 0.15 6.65% 




(ng/µL) % Error 
Actual 
(ng/µL) % Error 
Actual 
(ng/µL) % Error 
Actual 
(ng/µL) % Error 
Actual 
(ng/µL) % Error 
500 494.2 +/- 7.1 1.15% 516.0 +/- 24.3 3.20% 556.7 +/- 47.3 11.33% 
250 255.7 +/- 4.6 2.28% 244.7 +/- 6.4 2.13% 260.7 +/- 18.0 4.27% 
125 128.9 +/- 5.3 3.15% 122.0 +/- 7.5 2.40% 124.0 +/- 3.5 0.80% 
62.5 64.87 +/- 4.02 3.79% 59.90 +/- 4.16 4.16% 46.43 +/- 6.93 25.71% 61.10 +/- 3.47 2.29% 
31.25 32.83 +/- 3.32 5.07% 29.43 +/- 3.40 5.81% 19.10 +/- 0.72 38.88% 29.37 +/- 1.01 6.03% 27.13 +/- 1.93 13.17% 
15.625 16.83 +/- 2.50 7.73% 14.83 +/- 2.11 5.07% 8.57 +/- 0.85 45.13% 14.53 +/- 0.74 6.99% 12.77 +/- 1.50 18.29% 
7.8125 8.67 +/- 2.23 10.93% 7.54 +/- 1.19 3.49% 4.02 +/- 0.28 48.50% 7.32 +/- 0.31 6.26% 5.70 +/- 0.75 27.04% 
3.90625 4.57 +/- 1.70 16.91% 3.75 +/- 0.87 4.00% 1.99 +/- 0.20 49.14% 3.52 +/- 0.26 9.97% 2.90 +/- 0.22 25.76% 
1.953125 2.80 +/- 1.73 43.36% 1.88 +/- 0.57 3.57% 0.99 +/- 0.06 49.33% 1.84 +/- 0.17 5.96% 1.44 +/- 0.07 26.27% 
0.976563 1.60 +/- 1.40 63.84% 1.17 +/- 0.11 19.81% 0.50 +/- 0.04 48.77% 1.12 14.69% 0.72 +/- 0.08 26.48% 
Table S2. Time Estimates of a Test Cycle in TX-TL.  Time needed for rapid assembly in vitro 






PCR of segments na  1 h 15 min 
DpnI digest
2, 3 
na 5 min 
Assembly reaction
4 
1 h 1 h 
Transformation and Recovery na 1 h 30 min 
Overnight growth on plates na 16 h 
Colony isolation and liquid media growth na 8 h 
Miniprep na 30 min 
PCR of rapid assembly product
 
1 h 15 min  
PCR Cleanup
3 
15 min 15 min 
Setup TX-TL 15 min 15 min 
TOTAL pre-TX-TL 2 h 45 min 1 d + 
TOTAL post-TX-TL 4 h – 8 h 1 d + 
 
1
 Rapid Assembly assumes the use of premade, re-usable modular parts – if these are not 
available, add 1 h 20 min to predicted time and follow beginning of “Conventional Techniques” 
protocol. 
2
 Assumes the use of a fast-digest enzyme. 
3
 During digest, run the previous reaction on an agarose gel to determine purity and reaction 
completion. 
4
 Golden Gate Assembly has multiple protocols, from 1h to 3h20min in length. Protocol listed 
here assumes 10 cycles of 2min/37°C, 3min/20°C, 1 cycle 5min/50°C, 5min/80°C. Difficult 
assemblies can be accomplished by increasing cycling steps or by doing a constant at 37°C. 





Figure S1. Comparing spectrophotomeric and fluorometric quantifications of linear and 
plasmid DNA. (graphic). a) 2 µL of 1kb linear ladder DNA at the expected ng/µL is either 
measured in the Nanodrop or the Qubit fluorometer using the dsDNA BR assay or dsDNA HS 
assay. Error bars represent a standard deviation from three independent samples, and “na” 
indicates out of range of the machine. b) Same process as a), but with supercoiled plasmid ladder 
DNA. BR linear standard: supplied with Qubit dsDNA BR Assay kit; HS linear standard: 
supplied with Qubit dsDNA HS Assay kit; BR plasmid standard: pUC19 plasmid DNA of known 
concentration at 0 ng/µL and 100 ng/µL in TE buffer; HS plasmid standard: pUC19 at 0 ng/µL 




Figure S2. Effects of different additives on TX-TL efficiency. A variety of different additives 
commonly used in protein buffers are tested for toxicity. Endpoint fluorescence after 8 hours is 
determined for 1nM of pBEST-OR2-OR1-Pr-UTR1-deGFP-T500 at the final working 
concentrations listed in TX-TL or at 1:5 dilutions. Percent wildtype activity is against a control 
with no additive. Error bars represent one standard deviation from three independent 
































































































































































































Figure S3. Purification of gamS protein into gamS storage buffer S. a) GamS protein is 
purified, expressed, and concentrated into 3 mg/ml as described in “Materials and Methods.” 
Shown is the Coomassie Brilliant Blue stain of the purification procedure. b) Buffer toxicity of 
gamS storage buffer in TX-TL at different dilutions. Storage buffer composition (“buffer S”) is 
50 mM Tris-Cl pH 7.5, 100 mM NaCl, 1 mM DTT, 1 mM EDTA, 2% DMSO. Experiment is 
done in extract “e10.” 
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Figure S4. Effect of incubation time of gamS protein on linear protection. GamS protein to 
the listed concentration is added either directly to the crude cell extract for 30 minutes at room 
temperature (“incubation,” square-x) or directly to the DNA (“no incubation,” black-x). In the 
“incubation” case, crude cell extract incubated with gamS protein is then moved to 4°C and 
added to DNA. In the “no incubation” case, crude cell extract at 4°C is added directly to a mix of 
DNA and gamS protein. Reaction is run with 2 nM of linear DNA with no protection, and 
deGFP endpoint signal is measured. Error bars represent one standard deviation from three 
independent experiments.   


















Figure S5. Definition of linear regime and saturation regime in TX-TL. Cartoon diagram 
shows hypothetical reaction with reporter protein, where rate of signal increase with DNA is 
constant up to 4 nM (“linear regime”, green), begins to slow from 4 nM to 7 nM before 
becoming 0 above 7 nM (“saturation regime,” red). The linear regime is not resource-limited, 
while the saturation regime is resource limited. Purple semicircle: RNA polymerase; green oval: 
ribosome; grey lines: DNA; red line: mRNA; pink squiggly: protein.  
Figure S6. Protection of linear constructs with varying amounts of phosphorothioates. a) 
Endpoint expression of 2 nM linear DNA with 0, 2, or 5 phosphorothioates (“PT”) on the 5” end 
on constructs with 0 bp, 5 bp, or 250 bp of non-coding DNA protection. b) Top, time-series data 
of expression from 2nM of a linear DNA construct with no non-coding sequence protection on 
either side of promoter OR2-OR-Pr and of terminator. All data series are scaled to an endpoint 
expression of 1.0 after 8 hours. Below, nucleotide sequence of the left side of the construct, with 
operator, promoter -35 and -10, and phosphorothioate sites notated.
2
 Error bars represent one 
standard deviation from three independent experiments. Linear DNA is protected with gamS. 
  
Figure S7. Degradation of saturating amounts of DNA in extracts prepared at different 
temperatures with and without gamS protein. Degradation rates of 250 ng (20 nM) of linear 
DNA with AlexaFluor-584 labeled dUTPs over time in extract produced at 37°C (extract 
“eZS1”) or 29°C (extract “e13”). Signal is scaled to maximum DNA levels at time t=0. Error 





Figure S8: Comparison of strengths of different promoters using maximum measured 
amounts of DNA in TX-TL. a) Figure 4a is repeated for constitutive promoters but using 
maximum measured amounts of plasmid and linear DNA. b) Figure 4b is repeated for inducible 
promoters expressed constitutively.  
 
 
Figure S9. Individual traces of saturation curves. Saturation curves similar to Figure 4d, 
plotted for all promoters. r
2 
and linear regression line are based on a cutoff of 0.975 and 
correspond to data from Table 1. Linear DNA is protected with 250bp of steric protection and 
with gamS. Error bars represent one standard deviation from three independent experiments. 
 
  
Figure S10.  Rapid assembly and testing of a negative feedback gene. a) A four-piece 
negative feedback gene is assembled from standard pieces. b) Comparison by agarose gel 
electrophoresis of rapid assembly product made by Isothermal assembly (“RAP-iso”), rapid 
assembly product made by Golden Gate assembly (“RAP-GGA”), and post-cloned PCR product 
(“pos”). Arrow indicates expected band. Linear DNA is protected with 250 bp of steric 
protection and with gamS. c) Functional testing of 6 nM of rapid assembly products compared to 










































 Figure S11.  Overview of standard cloning procedure. a) A five-piece standard adopted with 
specific ligation ends for a promoter, 5’ UTR, coding sequence, terminator, and vector based on 
the previously used pBEST backbone. b) Diagram of sequences for ligation at each site. 
  
Figure S12. Purity of rapid assembly product as a function of template concentration and 
of overlapping primers. For a standard 5-piece assembly, the rapid assembly product (“RAP”) 
is amplified off 1 µL, 2 µL, or 5 µL of template in a 50 µL PCR reaction. A post-cloned PCR 
product (“pos”) is also produced. Non-overlapping primers refer to binding sites that do not cross 
the assembly junction between the vector and promoter and the vector and terminator; 
overlapping primers cross this junction. White arrow: template DNA; Blue arrows: Non-specific 
products removed by overlapping primers; Red arrow: non-specific products retained by 
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Figure S13: Rapid assembly of genetic switch. a) A four-piece genetic switch, identical to that 
in Figure 5a. b) Comparison of rapid assembly product (“RAP”) to post-cloned PCR product 
(“pos”) for four linear pieces formed, using overlap primers. c) Functional assay of RAP 
products versus post-cloned PCR products for “on” or “off” states of genetic switch. 2 nM of 
reporter and 1 nM of repressor is tested, and “+ IPTG” indicates the 0.5 mM IPTG, 0 µM aTc 
state while “- IPTG” indicates the 0 mM IPTG, 10 µM aTc state. Linear DNA is protected with 
31 bp of steric protection and with gamS.  Error bars represent one standard deviation from three 
independent experiments.   
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